KoreaMed Synapse

1

Relative efficacy of systemic treatments for patients with relapsed/refractory chronic lymphocytic leukemia: a network meta‑analysis according to 17p deletion/TP53 mutations

Jinchul Kim, Jinhyun Cho, Joo Han Lim, Moon Hee Lee

KMSID: 1516090205 Blood Res. 2025;60:1. Published online 2025 January 2 DOI: http://dx.doi.org/10.1007/s44313-024-00038-2

2

Pseudo Chediak‑Higashi anomaly in a diffuse large B‑cell lymphoma with hemophagocytic lymphohistiocytosis

Biyun Yi, Mengying Zeng

KMSID: 1516090216 Blood Res. 2025;60:2. Published online 2025 January 8 DOI: http://dx.doi.org/10.1007/s44313-024-00052-4

4

Efficacy of bortezomib combined with Hyper-CVAD in adults with relapsed acute lymphoblastic leukemia or positive measurable residual disease; effect of bortezomib in leukemia

Christian Omar Ramos Peñafiel, Daniela Pérez Sámano, Adán Germán Gallardo Rodríguez, Camila Terreros Palacio, Irma Olarte Carrillo, Carlos Martínez Murillo, Gilberto Barranco Lampón, Álvaro Cabrera García, Adolfo Martínez Tovar

KMSID: 1516090223 Blood Res. 2025;60:4. Published online 2025 January 14 DOI: http://dx.doi.org/10.1007/s44313-024-00050-6

5

Post-transplant cyclophosphamide plus anti-thymocyte globulin decreased serum IL-6 levels when compared with post-transplant cyclophosphamide alone after haploidentical hematopoietic stem cell transplantation

Jeong Suk Koh, Myung‑Won Lee, Thi Thuy Duong Pham, Bu Yeon Heo, Suyoung Choi, Sang‑Woo Lee, Wonhyoung Seo, Sora Kang, Seul Bi Lee, Chul Hee Kim, Hyewon Ryu, Hyuk Soo Eun, Hyo‑Jin Lee, Hwan‑Jung Yun, Deog‑Yeon Jo, Ik‑Chan Song

KMSID: 1516090224 Blood Res. 2025;60:5. Published online 2025 January 15 DOI: http://dx.doi.org/10.1007/s44313-024-00049-z

7

Comparing haploidentical transplantation with post-transplantation cyclophosphamide and umbilical cord blood transplantation using targeted busulfan in children and adolescents with hematologic malignancies

Kyung Taek Hong, Bo Kyung Kim, Hong Yul An, Jung Yoon Choi, Sang Hoon Song, Kyung‑Sang Yu, In‑Jin Jang, Hyoung Jin Kang

KMSID: 1516090225 Blood Res. 2025;60:7. Published online 2025 January 23 DOI: http://dx.doi.org/10.1007/s44313-025-00057-7

8

Reversibility of acrocyanosis and improvement of capillaroscopic pattern in a patient with polycythemia vera treated with ruxolitinib: a case report

Angelo Nigro

KMSID: 1516090226 Blood Res. 2025;60:8. Published online 2025 January 30 DOI: http://dx.doi.org/10.1007/s44313-024-00053-3

9

Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions

Sung-Hoon Jung, Youngil Koh, Min Kyoung Kim, Jin Seok Kim, Joon Ho Moon, Chang-Ki Min, Dok Hyun Yoon, Sung-Soo Yoon, Je-Jung Lee, Chae Moon Hong, Ka-Won Kang, Jihyun Kwon, Kyoung Ha Kim, Dae Sik Kim, Sung Yong Kim, Sung-Hyun Kim, Yu Ri Kim, Young Rok Do, Yeung-Chul Mun, Sung-Soo Park, Young Hoon Park, Ho Jin Shin, Hyeon-Seok Eom, Sang Eun Yoon, Sang Mee Hwang, Won Sik Lee, Myung-won Lee, Jun Ho Yi, Ji Yun Lee, Ji Hyun Lee, Ho Sup Lee, Sung-Nam Lim, Jihyang Lim, Ho-Young Yhim, Yoon Hwan Chang, Jae-Cheol Jo, Jinhyun Cho, Hyungwoo Cho, Yoon Seok Choi, Hee jeong Cho, Ari Ahn, Jong Han Choi, Hyun Jung Kim, Kihyun Kim

KMSID: 1516090227 Blood Res. 2025;60:9. Published online 2025 February 4 DOI: http://dx.doi.org/10.1007/s44313-025-00055-9

10

Real-world effectiveness and safety of rituximab and reduced-dose CHP with polatuzumab vedotin (pola-R-CHP) in patients aged > 80 years with diffuse large B-cell lymphoma: a retrospective analysis

Shuku Sato, Shun Tsunoda, Wataru Kamata, Tomiteru Togano, Yotaro Tamai

KMSID: 1516090206 Blood Res. 2025;60:10. Published online 2025 February 5 DOI: http://dx.doi.org/10.1007/s44313-025-00059-5

11

Is t(11;14) in newly diagnosed multiple myeloma a favorable outcome in the novel agent era?

Ye Li, Jingjing Deng, Yuan Jian, Zhiyao Zhang, Wenming Chen

KMSID: 1516090207 Blood Res. 2025;60:11. Published online 2025 February 6 DOI: http://dx.doi.org/10.1007/s44313-025-00056-8

12

Prognostic factors and treatment outcomes of allogeneic stem cell transplantation in lymphoid malignancy

Hyungsoon Kim, Haerim Chung, Hye Won Kook, Soo-Jeong Kim, Yu Ri Kim, Hyunsoo Cho, June-Won Cheong

KMSID: 1516090208 Blood Res. 2025;60:12. Published online 2025 February 10 DOI: http://dx.doi.org/10.1007/s44313-025-00060-y

13

Rosai-Dorfman disease disguised as BRAF V600E-positive histiocytosis – a diagnostic pitfall

Aishwarya Ravindran, Gaurav Goyal, Diana Morlote, Alexander C. Mackinnon

KMSID: 1516090209 Blood Res. 2025;60:13. Published online 2025 February 28 DOI: http://dx.doi.org/10.1007/s44313-025-00061-x

14

A case of dimethyl sulfoxide‑induced seizure in multiple myeloma

Ho Cheol Jang, Ga‑Young Song, Mihee Kim, Seo‑Yeon Ahn, Jae‑Sook Ahn, Deok‑Hwan Yang, Hyeoung‑Joon Kim, Je‑Jung Lee, Sung‑Hoon Jung

KMSID: 1516090210 Blood Res. 2025;60:14. Published online 2025 March 4 DOI: http://dx.doi.org/10.1007/s44313-025-00063-9

15

Transforming hematological research documentation with large language models: an approach to scientific writing and data analysis

John Jeongseok Yang, Sang‑Hyun Hwang

KMSID: 1516090211 Blood Res. 2025;60:15. Published online 2025 March 6 DOI: http://dx.doi.org/10.1007/s44313-025-00062-w

16

Correspondence: “Association of CD40 gene polymorphisms and immune thrombocytopenic purpura in the adult Egyptian population”

Elsayed Abdelkreem

KMSID: 1516090212 Blood Res. 2025;60:16. Published online 2025 March 7 DOI: http://dx.doi.org/10.1007/s44313-025-00066-6

17

Clonal hematopoiesis: elements associated with clonal expansion and diseases

Gangpyo Ryu, Youngil Koh, Siddhartha Jaiswal, Sung‑soo Yoon

KMSID: 1516090214 Blood Res. 2025;60:17. Published online 2025 March 13 DOI: http://dx.doi.org/10.1007/s44313-025-00065-7

18

Diffuse large B‑cell lymphoma presenting as acute adrenal hemorrhage

Fabio Torres, Uriel Suárez, Paola Pizano

KMSID: 1516090213 Blood Res. 2025;60:18. Published online 2025 March 19 DOI: http://dx.doi.org/10.1007/s44313-025-00064-8

19

Seroprevalence of SARS‑CoV‑2 antibodies in patients with hematological and oncological diseases in early 2024

Louise M. Cremer, Jannik Stemler, Rosanne Sprute, Sebastian Herrmann, Theresa Markus, Jon Salmanton‑García, Lutz Gieselmann, Veronica Di Cristanziano, Henning Gruell, Oliver A. Cornely, Sibylle C. Mellinghoff

KMSID: 1516090215 Blood Res. 2025;60:19. Published online 2025 March 28 DOI: http://dx.doi.org/10.1007/s44313-025-00067-5

20

Clinical features and outcomes of JAK2 unmutated erythrocytosis

Jeong Suk Koh, Wonhyoung Seo, Sora Kang, Myung‑Won Lee, Ik‑Chan Song, Deog‑Yeon Jo

KMSID: 1516090217 Blood Res. 2025;60:20. Published online 2025 March 31 DOI: http://dx.doi.org/10.1007/s44313-025-00072-8

21

Efficacy and safety of thalidomide with hydroxyurea in sickle cell anemia: a quasi‑experimental clinical trial

Priyanka Samal, Anindita Paul, Harshwardhan Bahirat, Ajit Kumar Bishoyi, Venkatarao Epari

KMSID: 1516090218 Blood Res. 2025;60:21. Published online 2025 April 1 DOI: http://dx.doi.org/10.1007/s44313-025-00068-4

22

Frequent association of malignant effusions in plasmablastic lymphoma: a single-institutional experience of nine cases in Taiwan

Bo-Jung Chen, Yu-Ting Kuo, Sheng-Tsung Chang, Khin-Than Win, Shang-Wen Chen, Sheng-Yen Hsiao, Yin-Hsun Feng, Yen-Chuan Hsieh, Shih-Sung Chuang

KMSID: 1516090219 Blood Res. 2025;60:22. Published online 2025 April 7 DOI: http://dx.doi.org/10.1007/s44313-025-00070-w

24

Analysis of hemolysis-associated acute myeloid leukemia genes obtained using weighted gene co-expression network analysis and a Mendelian randomization study

Rui Zhang, Yan Zang, Linguo Wan, Hui Yu, Zhanshan Cha, Haihui Gu

KMSID: 1516090220 Blood Res. 2025;60:24. Published online 2025 April 11 DOI: http://dx.doi.org/10.1007/s44313-025-00073-7

25

Very low-dose vemurafenib maintenance for cardiac Erdheim Chester disease

Abhijeet Kumar Agrawal, Pronamee Borah, P. D. Rath, Rahul Naithani

KMSID: 1516090222 Blood Res. 2025;60:25. Published online 2025 April 11 DOI: http://dx.doi.org/10.1007/s44313-025-00075-5

26

Real-world treatment patterns, outcomes, and economic costs by lines of therapy in patients with newly diagnosed multiple myeloma: a nationwide population-based cohort study in South Korea

Sung‑Soo Park, YoungJu Park, Soomin Yoon, Doik Lee, Jihyeon Jeong, Kihyun Kim

KMSID: 1516090221 Blood Res. 2025;60:26. Published online 2025 April 15 DOI: http://dx.doi.org/10.1007/s44313-025-00069-3

27

Real‑world data analysis of survival outcomes of patients with primary mediastinal large B‑cell lymphoma treated with immunochemotherapy: the role of consolidative radiation therapy

Yong‑Pyo Lee, Junhun Cho, Young Hyeh Ko, Dongryul Oh, Seok Jin Kim, Won Seog Kim, Sang Eun Yoon

KMSID: 1516090725 Blood Res. 2025;60:27. Published online 2025 April 22 DOI: http://dx.doi.org/10.1007/s44313-025-00076-4

28

Atypical features of hepatic veno‑occlusive disease/sinusoidal obstruction syndrome after inotuzumab ozogamicin in adult patients with acute lymphoblastic leukemia

Kyung‑Hun Sung, Daehun Kwag, Gi June Min, Sung‑Soo Park, Silvia Park, Sung‑Eun Lee, Byung‑Sik Cho, Ki‑Seong Eom, Yoo‑Jin Kim, Hee‑Je Kim, Chang‑Ki Min, Seok‑Goo Cho, Seok Lee, Jae‑Ho Yoon

KMSID: 1516090724 Blood Res. 2025;60:28. Published online 2025 April 22 DOI: http://dx.doi.org/10.1007/s44313-025-00077-3

29

The correlation between serum complement levels and clinical presentation in Egyptian immune thrombocytopenia patients

Nourhan Mohamed Nasr, Alia Abdelaziz Ayad, Noha Khalifa Abdelghaffar, Marwa Salah Mohamed

KMSID: 1516090726 Blood Res. 2025;60:29. Published online 2025 May 6 DOI: http://dx.doi.org/10.1007/s44313-025-00078-2

30

Diagnosis and management of neutropenia

Kyoung Il Min, Seonggyu Byeon

KMSID: 1516092030 Blood Res. 2025;60:30. Published online 2025 May 26 DOI: http://dx.doi.org/10.1007/s44313-025-00079-1

31

Correction: Selected Articles in Blood Research, volume 60

Blood Research

KMSID: 1516092031 Blood Res. 2025;60:31. Published online 2025 May 26 DOI: http://dx.doi.org/10.1007/s44313-025-00083-5

32

Cell‑based artificial platelet production: historical milestones, emerging trends, and future directions

Kyoung Mi Kim, Koudai I. Albaira, Jayoung Kang, Yong Gon Cho, Soon Sung Kwon, Jaecheol Lee, Dae‑Hyun Ko, Sinyoung Kim, Seung Yeob Lee

KMSID: 1516092035 Blood Res. 2025;60:32. Published online 2025 May 27 DOI: http://dx.doi.org/10.1007/s44313-025-00071-9

33

CMV infections after HSCT: prophylaxis and treatment

Haerim Chung

KMSID: 1516092032 Blood Res. 2025;60:33. Published online 2025 June 3 DOI: http://dx.doi.org/10.1007/s44313-025-00081-7

34

Impact of HLA locus mismatch on peripheral blood allogeneic hematopoietic stem cell transplantation from unrelated donors using an ATG‑based GVHD prophylaxis strategy

Jiawen Wang, Yanping Liu, Han Zhu, Kourong Miao

KMSID: 1516092033 Blood Res. 2025;60:34. Published online 2025 June 3 DOI: http://dx.doi.org/10.1007/s44313-025-00082-6

35

Treatment of older patients with Hodgkin lymphoma

Chung Hyun Park, Hyunsoo Cho, Soo‑Jeong Kim

KMSID: 1516092034 Blood Res. 2025;60:35. Published online 2025 June 12 DOI: http://dx.doi.org/10.1007/s44313-025-00084-4

36

Genomic risk factors for central nervous system relapse in patients with diffuse large B‑cell lymphoma

Shiyu Jiang, Qunling Zhang, Jia Jin, Wenhao Zhang

KMSID: 1516092036 Blood Res. 2025;60:36. Published online 2025 July 1 DOI: http://dx.doi.org/10.1007/s44313-025-00087-1

37

Effusion cytology of EBV‑associated lymphoma: a concise review

Chih‑Yi Liu, Yen‑Chuan Hsieh, Sheng‑Tsung Chang, Hung‑Chang Wu, Shang‑Wen Chen, Shih‑Sung Chuang

KMSID: 1516092037 Blood Res. 2025;60:37. Published online 2025 July 2 DOI: http://dx.doi.org/10.1007/s44313-025-00088-0

38

SOX4 in chronic lymphocytic leukaemia: the forgotten transcription factor

Ricardo García‑Muñoz, Jone Alberdi‑Ballina, Giovanna Farfan‑Quiroga, Eloy F. Robles, María José Larráyoz, María José Calasanz, José Ángel Martínez‑Climent, Carlos Panizo, Javier Larreina‑Pérez, Sofía Rincón‑López, Johelys Atencio‑Matos, Andrea Campeny‑Najara, Ada Esteban‑Figuerola, Montserrat Hernandez‑Perez, Puy Garrastachu‑Zumaran, María Velasco‑Ruiz, Estefanía Ruiz de Gaona, Jesús Feliu

KMSID: 1516092038 Blood Res. 2025;60:38. Published online 2025 July 4 DOI: http://dx.doi.org/10.1007/s44313-025-00086-2

39

Real‑world apixaban concentration in Korean patients with atrial fibrillation

Sun Hack Lee, Mijin Kim, Min Sun Kim, Jeongcheon Choe, Jinhee Ahn, Hyewon Lee, Junghyun Choi, Han Cheol Lee, Hyerim Kim, Kwang Soo Cha

KMSID: 1516092544 Blood Res. 2025;60:39. Published online 2025 July 7 DOI: http://dx.doi.org/10.1007/s44313-025-00089-z

40

Improved survival in pediatric acute lymphoblastic leukemia through therapy intensification based on minimal residual disease and protocol‑driven early response risk classification

Hyery Kim, Su Hyun Yoon, Sunghan Kang, Kyung‑Nam Koh, Ho Joon Im, Daehyun Chu, Mi Young Kim, Young‑Uk Cho, Sang‑Hyun Hwang, Seongsoo Jang

KMSID: 1516092545 Blood Res. 2025;60:40. Published online 2025 July 9 DOI: http://dx.doi.org/10.1007/s44313-025-00085-3

41

Current practices in peripheral blood stem cell processing and cryopreservation: a nationwide survey of Korean transplant centers

Soo‑Kyung Kim, Jaeeun Yoo, Jong‑Han Lee, Ha‑Eun Lee, Jae‑Sook Ahn, Kyung‑Nam Koh, Byung‑Sik Cho, Seong‑Kyu Park, Ho Joon Im, Hyunji Lee, Sun‑Young Kong

KMSID: 1516092549 Blood Res. 2025;60:41. Published online 2025 July 22 DOI: http://dx.doi.org/10.1007/s44313-025-00090-6

42

Impact of CD34⁺ cell dose on outcomes of haploidentical peripheral blood stem cell transplantation in acute leukemia

Haerim Chung, Hye Won Kook, Hyunsoo Cho, Ji Eun Jang, June‑Won Cheong

KMSID: 1516092547 Blood Res. 2025;60:42. Published online 2025 August 7 DOI: http://dx.doi.org/10.1007/s44313-025-00091-5

43

Interleukin‑10 augments human endogenous retroviral E1B variant of cd5 in aged T cells

Bharat Singh, Smita Kumari, Amit Kumar Kureel, Arunim Shah, Shobhita Katiyar, Chandra Prakash Chaturvedi, Kulwant Singh, Ambak Kumar Rai

KMSID: 1516092548 Blood Res. 2025;60:43. Published online 2025 August 11 DOI: http://dx.doi.org/10.1007/s44313-025-00080-8

44

A comprehensive analysis of the role of stem cell transplantation in mantle cell lymphoma: real‑world data from the Korean Society of Blood and Marrow Transplantation registry: Stem cell transplantation outcomes in mantle cell lymphoma

Dong Won Baek, Joon Ho Moon, Jae Hoon Lee, Ka‑Won Kang, Ho Sup Lee, Hyeon‑Seok Eom, Eunyoung Lee, Ji Hyun Lee, Jeong‑Ok Lee, Seong Kyu Park, Seok Jin Kim, Youngil Koh, Jong‑Ho Won, Jung‑Hee Lee, Joon Seong Park, Jae‑Cheol Jo, Yeung‑Chul Mun, Deok‑Hwan Yang, Ga‑Young Song, Sung‑Nam Lim, Sang Kyun Sohn, the Korean Society of Blood, Marrow Transplantation

KMSID: 1516092546 Blood Res. 2025;60:44. Published online 2025 August 13 DOI: http://dx.doi.org/10.1007/s44313-025-00092-4

45

Hepatitis B virus reactivation in patients with hematologic malignancies treated with Bruton tyrosine kinase inhibitors

Joon Young Hur, Jung‑Hee Lee, Je‑Hwan Lee, Han‑Seung Park, Hyunkyung Park, Yunsuk Choi, Jung Hye Choi, Young‑Woong Won, Sang Eun Yoon, Won Seog Kim, Seok Jin Kim

KMSID: 1516092550 Blood Res. 2025;60:45. Published online 2025 August 15 DOI: http://dx.doi.org/10.1007/s44313-025-00093-3

46

Association of product of platelet and neutrophil count with monoclonal gammopathy of undetermined significance: a cross‑sectional analysis of the NHANES

Lijie Wang, Peiyao Yang, Huijie Nan, Wenqian Li, Yuanyuan Liu, Fangfang Xu, Mingyue Shi, Yanliang Bai

KMSID: 1516092552 Blood Res. 2025;60:46. Published online 2025 August 18 DOI: http://dx.doi.org/10.1007/s44313-025-00094-2

47

Real‑world data on long‑term outcomes in patients with T‑cell lymphomas: a nationwide study of Korea

Dong Won Baek, Jung Min Lee, Youngeun Jang, Yunji Lee, Hee Jeong Cho, Joon Ho Moon, Hasung Kim, Hoseob Kim, Sang Kyun Sohn

KMSID: 1516092553 Blood Res. 2025;60:47. Published online 2025 August 21 DOI: http://dx.doi.org/10.1007/s44313-025-00095-1

48

Progression of carotid plaque burden in patients with polycythemia vera and essential thrombocythemia

Seong Soon Kwon, Sun Young Jeong, Min‑Young Lee, Kyoung Ha Kim, Namsu Lee, Jong‑Ho Won, Seug Yun Yoon

KMSID: 1516092551 Blood Res. 2025;60:48. Published online 2025 September 1 DOI: http://dx.doi.org/10.1007/s44313-025-00098-y

49

RUNX1 alterations and survival outcomes in AML: leukocyte dynamics and thrombocytosis insights from an Indonesian cohort

Ikhwan Rinaldi, Elly Yanah Arwanih, Kevin Winston, Farida Farah Adibah, Yuli Maulidiya Shufiyani, Rafida Amalia Salma

KMSID: 1516092554 Blood Res. 2025;60:49. Published online 2025 September 1 DOI: http://dx.doi.org/10.1007/s44313-025-00096-0

50

Does the current apixaban dosing strategy adequately fit and ensure safety in Korean patients with atrial fibrillation?

Bohyun Kim

KMSID: 1516092848 Blood Res. 2025;60:50. Published online 2025 September 8 DOI: http://dx.doi.org/10.1007/s44313-025-00103-4

51

Molecular spectrum and carrier frequency of deletional hereditary persistence of fetal hemoglobin and delta‑beta thalassemia in Malaysia

Faidatul Syazlin Abdul Hamid, Sabariah Md Noor, Mei I Lai, Samsol Kamal Mohd Bahari, Ezalia Esa, Ermi Neiza Mohd Sahid, Norafiza Mohd Yasin, Yuslina Mat Yusoff

KMSID: 1516092849 Blood Res. 2025;60:51. Published online 2025 September 29 DOI: http://dx.doi.org/10.1007/s44313-025-00100-7

52

Novel agents and evolving strategies for anemia management in lower‑risk myelodysplastic syndromes

Junshik Hong

KMSID: 1516092850 Blood Res. 2025;60:52. Published online 2025 September 30 DOI: http://dx.doi.org/10.1007/s44313-025-00099-x

53

Treatment of transplant‑ineligible multiple myeloma

Jongheon Jung

KMSID: 1516092851 Blood Res. 2025;60:53. Published online 2025 October 9 DOI: http://dx.doi.org/10.1007/s44313-025-00102-5

54

Tandem autologous stem cell transplant in multiple myeloma patients with minimal residual disease: an explorative study

Sieun Oh, Sung‑Soo Park, Jung Yeon Lee, Jae‑Ho Yoon, Sung‑Eun Lee, Hee‑Je Kim, Seung‑Hwan Shin, Young‑Woo Jeon, Seung‑Ah Yahng, Jin Jung, Ari Ahn, Myungshin Kim, Chang‑Ki Min

KMSID: 1516092852 Blood Res. 2025;60:54. Published online 2025 October 23 DOI: http://dx.doi.org/10.1007/s44313-025-00101-6

55

Aggressive natural killer cell leukemia therapy in the L‑asparaginase era: why are we failing?

Sang Eun Yoon, Junhun Cho, Hyun‑Young Kim, Seok Jin Kim, Won Seog Kim

KMSID: 1516092853 Blood Res. 2025;60:55. Published online 2025 October 23 DOI: http://dx.doi.org/10.1007/s44313-025-00104-3

56

Unveiling the role of microRNAs, the PI3K/ AKT pathway, and their associations in various types of leukemia: a comprehensive review

Amir Modarresi Chahardehi, Esfandiar Mali, Arya Afrooghe, Amirmasoud Asadi, Amirreza Khalaji, Hamed Soleimani Samarkhazan, Hananeh Esmaeil Beygi, Amirhossein Mohagheghi, Maryam Khanbabaei, Heliya Haghani, Reza Arefnezhad, Fatemeh Rezaei‑Tazangi

KMSID: 1516094146 Blood Res. 2025;60:56. Published online 2025 November 3 DOI: http://dx.doi.org/10.1007/s44313-025-00107-0

57

Early CD4 + T cell immune reconstitution as a biomarker for Epstein‑Barr virus control following allogeneic transplantation

Kexin Lin, Wenwen Yang, Jiaxiu Yin, Jing Luo, Hao Zhou, Lanxiang Liu, Li Yang, Jie Luo, Lin Liu, Junli Mou

KMSID: 1516094147 Blood Res. 2025;60:57. Published online 2025 November 4 DOI: http://dx.doi.org/10.1007/s44313-025-00106-1

58

Beyond anemia: unraveling neutrophil defects and infection susceptibility in β‑Thalassemia

Chingiz Asadov, Gunay Aliyeva

KMSID: 1516094148 Blood Res. 2025;60:58. Published online 2025 November 11 DOI: http://dx.doi.org/10.1007/s44313-025-00108-z

59

Durable responses and favorable cost‑effectiveness of rituximab‑based chemoimmunotherapy for primary cold agglutinin disease

Kenichi Ito, Tomoko Kitagawa, Saya Motohashi, Kazuhiko Hirano, Naohiro Sekiguchi

KMSID: 1516094149 Blood Res. 2025;60:59. Published online 2025 November 11 DOI: http://dx.doi.org/10.1007/s44313-025-00109-y

60

Current immunotherapeutic approaches for relapsed/refractory follicular lymphoma: bispecific antibodies and CAR T‑Cell therapies

So Yeon Park, Gi‑June Min

KMSID: 1516094150 Blood Res. 2025;60:60. Published online 2025 November 17 DOI: http://dx.doi.org/10.1007/s44313-025-00105-2

61

A comparative study of hematologic response to ropeginterferon alfa‑2b in hydroxyurea‑resistant or intolerant polycythemia vera: a real‑world data‑based analysis

Sung‑Eun Lee, Seug Yun Yoon, Sung‑Yong Kim, Soo‑Mee Bang, Insoo Lee, Jihyuk Lee, Junshik Hong

KMSID: 1516094151 Blood Res. 2025;60:61. Published online 2025 November 17 DOI: http://dx.doi.org/10.1007/s44313-025-00110-5

62

Brentuximab vedotin combined with cisplatin, cytarabine, and dexamethasone treatment in transplant-eligible Korean patients with relapsed or refractory Hodgkin’s lymphoma

Jun Ho Yi, Young Hoon Park, Myung‑won Lee, Kwai Han Yoo, Junshik Hong, Hyeon‑Seok Eom

KMSID: 1516094152 Blood Res. 2025;60:62. Published online 2025 November 21 DOI: http://dx.doi.org/10.1007/s44313-025-00097-z

63

Plasma interleukin‑12 levels as a potential biomarker of fatigue and quality of life in patients with primary immune thrombocytopenia

Sarthak Wadhera, Arihant Jain, Aarushi Sahni, Rudra Narayan Swain, Charanpreet Singh, Aditya Jandial, Ritu Aggarwal, Rekha Hans, Gaurav Prakash, Alka Khadwal, Sandeep Grover, Reena Das, Pankaj Malhotra

KMSID: 1516094154 Blood Res. 2025;60:63. Published online 2025 December 4 DOI: http://dx.doi.org/10.1007/s44313-025-00112-3

64

Insights into Treatment‑Free Remission (TFR) outcomes in Chronic Myeloid Leukaemia (CML) – a tertiary centre experience in Malaysia

Christopher Chin Keong Liam, Yang Liang Boo, Li Min Lim, Siew Lian Chong, Azizan Sharif, Yih Seong Wong, Veena Selvaratnam, Sen Mui Tan, Soo Min Lim

KMSID: 1516094153 Blood Res. 2025;60:64. Published online 2025 December 22 DOI: http://dx.doi.org/10.1007/s44313-025-00116-z

65

Invasive fungal infections in hematologic diseases: evidence, challenges, and clinical practice

Sung‑Yeon Cho, Chae Eun Lee, Dukhee Nho, Dong‑Gun Lee

KMSID: 1516094155 Blood Res. 2025;60:65. Published online 2025 December 12 DOI: http://dx.doi.org/10.1007/s44313-025-00113-2

66

Measurable residual disease monitoring after hematopoietic stem cell transplantation

Saeam Shin

KMSID: 1516094156 Blood Res. 2025;60:66. Published online 2025 December 30 DOI: http://dx.doi.org/10.1007/s44313-025-00121-2

67

Translational investigation of tolinapant (ASTX660) in acute myeloid leukemia by integrating clinical, bioinformatic and pharmacological approaches

Keli Lima, Frederico Lisboa Nogueira, Catarina Sofia Mateus Reis‑Silva, Rita de Cássia Cavaglieri, Leticia Veras Costa‑Lotufo, João Agostinho Machado‑Neto, Eduardo Magalhães Rego

KMSID: 1516094157 Blood Res. 2025;60:67. Published online 2025 December 30 DOI: http://dx.doi.org/10.1007/s44313-025-00117-y